Patient level: n, (%) | Intervention n = 1099 | Control N = 1055 | Risk ratio (95% CI) | p value |
---|---|---|---|---|
Primary outcome | ||||
 Appropriate treatment of malaria by CHWsa | 828 (75.3) | 185 (17.5) | 3.72 (2.40–5.77) | <0.001 |
Secondary outcomes | ||||
 Malaria negative patients prescribed antimalarial drug (n = 1875) | 95 (10.0) | 813 (87.6) | 0.11 (0.08–0.15) | <0.001 |
 P. falciparum malaria cases prescribed an ACT (n = 86) | 12 (28.6) | –b | – |  |
 P. vivax malaria cases prescribed CQ (n = 346) | 70 (45.1) | 164 (85.9) | 0.43 (0.31–0.59) | <0.001 |
 Malaria negative patients prescribed co-trimoxazole (n = 1756) | 613 (67.2) | 295 (35.0) | 1.98 (1.18–3.33) | 0.012 |
Referral practices: | ||||
 Referral on to formal health services (n = 2399) | 414 (34.6) | 317 (26.4) | 1.53 (0.89–2.63) | 0.116 |